Class IITerminated in FDA datasetJul 1, 2014

Kratom (Kr8om) Premium Bali Alkaloid Suspension Oil in 135 mg., 200 mg., and 300 mg. dosages and Kratom (KR8om) Bali Custom Alkaloid Suspension Oil in 175 mg dosage

Recalling firm: Nuevotanicals

Why it was recalled

These products contain Kratom.

Check your package

Compare the exact product and package details with the label you have.

ProductKratom (Kr8om) Premium Bali Alkaloid Suspension Oil in 135 mg., 200 mg., and 300 mg. dosages and Kratom (KR8om) Bali Custom Alkaloid Suspension Oil in 175 mg dosage

FDA code information

All products manfactured since 6/1/2011

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

Kratom (Kr8om) Premium Bali Alkaloid Suspension Oil in 135 mg., 200 mg., and 300 mg. dosages and Kratom (KR8om) Bali Custom Alkaloid Suspension Oil in 175 mg dosage

Recall details

Recall number
F-2410-2015
Event ID
68705
FDA status
Terminated
Initiated
Jul 1, 2014
Reported
Jun 17, 2015
Classified
Jun 8, 2015
Terminated
Mar 2, 2017
Quantity
52,552 units; 9 kg in bulk
Location
Fort Worth, TX, United States
Initiation type
Voluntary: Firm initiated
Notification
Letter

Where it was distributed

Alabama, Arizona, California, Florida, Illinois, Nevada, New York, Ohio, Oklahoma, Oregon, Texas, and Virginia.

FDA source record · F-2410-2015

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.